文献速递瓣膜外科

感染性心内膜炎三尖瓣修复的单中心病例系列

Tricuspid valve repair for infective endocarditis.
PubMed 文献 · Interdiscip Cardiovasc Thorac Surg · 2024-01-01

该病例系列纳入2001年2月至2020年12月在比利时布鲁塞尔圣吕克大学医院因原生三尖瓣急性或已愈感染性心内膜炎接受手术的全部患者,共31例;28例(90.3%)行三尖瓣修复,3例(9.7%)行二尖瓣同种移植物替换。作者认为,鉴于三尖瓣感染性心内膜炎多见于年轻患者,应以修复为首选;瓣膜严重损毁时可考虑使用心包补片,修复不可行时二尖瓣同种移植物是减少人工材料的补充方案。

要点

  • 31例中28例(90.3%)行三尖瓣修复,3例(9.7%)行二尖瓣同种移植物替换。
  • 院内死亡:替换组33.3%(n=1)vs 修复组7.1%(n=2),P=0.25。
  • 10年总体生存率75.6%(95%CI:52-89%);10年免于再次手术率在补片修复组与未用补片组间分别为59.3%(95%CI:7.6-89%)和93.7%(95%CI:63-99%),P=0.4。

核心结论

  • 作者认为,鉴于三尖瓣感染性心内膜炎多见于年轻患者,以修复为导向的策略应被视为首选。
  • 作者认为,瓣膜严重损毁时使用心包补片是可行的选择;若修复不可行,使用二尖瓣同种移植物是减少人工材料的补充有用方案。

研究设计与样本

  • 单中心病例系列,纳入2001年2月至2020年12月在比利时布鲁塞尔圣吕克大学医院因原生三尖瓣急性或已愈感染性心内膜炎接受手术的全部患者,共31例。
  • 修复组按术中是否使用补片分为两个亚组;替换组使用二尖瓣同种移植物。

主要发现

  • 31例中28例(90.3%)行三尖瓣修复,3例(9.7%)行二尖瓣同种移植物替换。
  • 院内死亡率:替换组33.3%(n=1)vs 修复组7.1%(n=2),P=0.25。
  • 10年总体生存率为75.6%(95%CI:52-89%)。
  • 10年免于三尖瓣再次手术率:补片修复组59.3%(95%CI:7.6-89%)vs 未用补片组93.7%(95%CI:63-99%),P=0.4。
  • 10年免于感染性心内膜炎复发率为87%(95%CI:51-97%)。

关键数值与推荐

  • 作者提出以修复为导向的策略应被视为三尖瓣感染性心内膜炎的首选;瓣膜严重损毁时可使用心包补片;修复不可行时可使用二尖瓣同种移植物以减少人工材料。

临床怎么用

  • 作者建议,三尖瓣感染性心内膜炎的治疗中,以修复为导向的策略应被视为首选。
  • 作者认为,瓣膜严重损毁时可使用心包补片。
  • 作者认为,修复不可行时使用二尖瓣同种移植物是减少人工材料的补充有用方案。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: The progressive increase in the use of implantable electronic devices, vascular access for dialysis and the increased life expectancy of patients with congenital heart diseases has led in recent years to a considerable number of right-side infective endocarditis, especially of the tricuspid valve (TV). Although current guidelines recommend TV repair for native tricuspid valve endocarditis (TVE), the percentage of valve replacements remains very high in numerous studies. The aim of our study is to analyse our experience in the treatment of TVE with a reparative approach. METHODS: This case series includes all the patients who underwent surgery for acute or healed infective endocarditis on the native TV, at the Cliniques Universitaires Saint-Luc (Bruxelles, Belgium) between February 2001 and December 2020. RESULTS: Thirty-one patients were included in the study. Twenty-eight (90.3%) underwent TV repair and 3 (9.7%) had a TV replacement with a mitral homograft. The repair group was divided into 2 subgroups, according to whether a patch was used during surgery or not. Hospital mortality was 33.3% (n = 1) for the replacement group and 7.1% (n = 2) for repair (P = 0.25). Overall survival at 10 years was 75.6% [95% confidence interval (CI): 52-89%]. Further, freedom from reoperation on the TV at 10 years was 59.3% (95% CI: 7.6-89%) vs 93.7% (95% CI: 63-99%) (P = 0.4) for patch repair and no patch use respectively. Freedom from recurrent endocarditis at 10 years was 87% (95% CI: 51-97%). CONCLUSIONS: Considering that TVE is more common in young patients, a repair-oriented approach should be considered as the first choice. In the case of extremely damaged valves, the use of pericardial patch is a valid option. If repair is not feasible, the use of a mitral homograft is an additional useful solution to reduce the prosthetic material.

来源:Interdiscip Cardiovasc Thorac Surg,查看原文。版权归原作者所有。

引用

  1. Lorenz V, Mastrobuoni S, Aphram G, et al. Tricuspid valve repair for infective endocarditis. Interdiscip Cardiovasc Thorac Surg. 2024. PMID: 38688562. doi:10.1093/icvts/ivae084

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。